scholarly journals Unconventional protein secretion – new insights into the pathogenesis and therapeutic targets of human diseases

2018 ◽  
Vol 131 (12) ◽  
pp. jcs213686 ◽  
Author(s):  
Jiyoon Kim ◽  
Heon Yung Gee ◽  
Min Goo Lee
Keyword(s):  
Protein Secretion ◽  
Therapeutic Targets ◽  
Human Diseases

scholarly journals Reinforcement Learning to Boost Molecular Docking upon Protein Conformational Ensemble

2021 ◽  
Author(s):  
Bin Chong ◽  
Yingguang Yang ◽  
Zi-Le Wang ◽  
Han Xing ◽  
Zhirong Liu
Keyword(s):  
Molecular Docking ◽  
Reinforcement Learning ◽  
Intrinsically Disordered Proteins ◽  
Therapeutic Targets ◽  
Human Diseases ◽  
Disordered Proteins ◽  
Conformational Ensemble ◽  
Intrinsically Disordered

Intrinsically disordered proteins (IDPs) widely involve in human diseases and are thus attractive therapeutic targets. In practice, however, it is computationally prohibitive to dock large ligand libraries to thousands and...

scholarly journals Application of microRNA Database Mining in Biomarker Discovery and Identification of Therapeutic Targets for Complex Disease

2020 ◽  
Vol 4 (1) ◽  
pp. 5
Author(s):  
Jennifer L. Major ◽  
Rushita A. Bagchi ◽  
Julie Pires da Silva
Keyword(s):  
Complex Disease ◽  
Biomarker Discovery ◽  
Ischemia Reperfusion Injury ◽  
Ischemia Reperfusion ◽  
Expression Patterns ◽  
Therapeutic Targets ◽  
Human Diseases ◽  
Mirna Expression Data ◽  
Artery Disease ◽  
Underlying Mechanisms

Over the past two decades, it has become increasingly evident that microRNAs (miRNA) play a major role in human diseases such as cancer and cardiovascular diseases. Moreover, their easy detection in circulation has made them a tantalizing target for biomarkers of disease. This surge in interest has led to the accumulation of a vast amount of miRNA expression data, prediction tools, and repositories. We used the Human microRNA Disease Database (HMDD) to discover miRNAs which shared expression patterns in the related diseases of ischemia/reperfusion injury, coronary artery disease, stroke, and obesity as a model to identify miRNA candidates for biomarker and/or therapeutic intervention in complex human diseases. Our analysis identified a single miRNA, hsa-miR-21, which was casually linked to all four pathologies, and numerous others which have been detected in the circulation in more than one of the diseases. Target analysis revealed that hsa-miR-21 can regulate a number of genes related to inflammation and cell growth/death which are major underlying mechanisms of these related diseases. Our study demonstrates a model for researchers to use HMDD in combination with gene analysis tools to identify miRNAs which could serve as biomarkers and/or therapeutic targets of complex human diseases.

scholarly journals LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19

2021 ◽  
Author(s):  
Hideyuki Shimizu ◽  
Manabu Kodama ◽  
Masaki Matsumoto ◽  
Yasuko Orba ◽  
Michihito Sasaki ◽  
...  
Keyword(s):  
Paradigm Shift ◽  
High Throughput Screening ◽  
Structural Information ◽  
Protein Structures ◽  
Therapeutic Targets ◽  
Basic Research ◽  
Human Diseases ◽  
Docking Simulations ◽  
Research Findings ◽  
Therapeutic Compounds

SUMMARYAlthough numerous promising therapeutic targets for human diseases have been discovered, most have not been successfully translated into clinical practice1. A bottleneck in the application of basic research findings to patients is the enormous cost, time, and effort required for high-throughput screening of potential drugs2 for given therapeutic targets. Recent advances in 3D docking simulations have not solved this problem, given that 3D protein structures with sufficient resolution are not always available and that they are computationally expensive to obtain. Here we have developed LIGHTHOUSE, a graph-based deep learning approach for discovery of the hidden principles underlying the association of small-molecule compounds with target proteins, and we present its validation by identifying potential therapeutic compounds for various human diseases. Without any 3D structural information for proteins or chemicals, LIGHTHOUSE estimates protein-compound scores that incorporate known evolutionary relations and available experimental data. It identified novel therapeutics for cancer, lifestyle-related disease, and bacterial infection. Moreover, LIGHTHOUSE predicted ethoxzolamide as a therapeutic for coronavirus disease 2019 (COVID-19), and this agent was indeed effective against alpha, beta, gamma, and delta variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are rampant worldwide. Given that ethoxzolamide is already approved for several diseases, it could be rapidly deployed for the treatment of patients with COVID-19. We envision that LIGHTHOUSE will bring about a paradigm shift in translational medicine, providing a bridge from bench side to bedside.

scholarly journals A Review of the Recent Advances Made with SIRT6 and Its Implications on Aging Related Processes, Major Human Diseases and Possible Therapeutic Targets

2018 ◽  
Author(s):  
Rubayat Islam Khan ◽  
Saif Nirzhor ◽  
Raushanara Akter
Keyword(s):  
Heart Disease ◽  
Neurodegenerative Diseases ◽  
Treatment Options ◽  
Therapeutic Targets ◽  
Human Diseases ◽  
Future Research ◽  
Molecular Pathways ◽  
Biomedical Sciences ◽  
Biochemical Activity ◽  
Life Threatening

SIRT6 is a NAD+ dependent enzyme and stress response protein that has sparked the curiosity of a plethora of researchers in different branches of the biomedical sciences. A unique member of the known Sirtuin family, SIRT6 has several different functions in several different molecular pathways related to DNA repair, glycolysis, gluconeogenesis, tumorigenesis, neurodegeneration, cardiac hypertrophic responses and so on. Only in recent times however did the potential usefulness of SIRT6 come to light as we learned more about its biochemical activity, regulation, biological roles and structure [1]. Even until very recently, SIRT6 was known more for chromatin signaling but being a nascent topic of study, more information has been ascertained and its potential involvement in major human diseases namely, diabetes, cancer, neurodegenerative diseases and heart disease has been demonstrated. It is pivotal to explore the mechanistic workings of SIRT6 since future research may hold the key to engendering strategies, involving SIRT6, that may have significant implications for human health and expand upon possible treatment options. In this review, we are primarily concerned with exploring the latest understanding of SIRT6 and how it can alter the course of several life-threatening diseases that cripple today’s society such as processes related to aging, cancer, neurodegenerative diseases, heart disease and diabetes. In addition, SIRT6 has shown to be involved in liver disease, inflammation and bone related issues but more emphasis is given to the former. Lastly, any recent promising pharmacological investigations and study of potential therapeutic targets are also delineated in this review.

Sign in / Sign up

Export Citation Format

Share Document